FDA Drug recall D-381-2014
0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02
- FDA Drug
- Class I
- terminated
- Published 2013-12-25
On 2013-12-25 the FDA classified a Class I recall of 0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02 by Hospira, citing presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-381-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-07-12 |
| Published | 2013-12-25 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02
Reason
Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.
Identifiers
| ndc | 0409-1159-18 |
|---|---|
| ndc | 0409-1159-01 |
| ndc | 0409-1159-19 |
| ndc | 0409-1159-02 |
| ndc | 0409-1160-18 |
| ndc | 0409-1160-01 |
| ndc | 0409-1162-18 |
| ndc | 0409-1162-01 |
| ndc | 0409-1162-19 |
| ndc | 0409-1162-02 |
| ndc | 0409-1163-18 |
| ndc | 0409-1163-01 |
| ndc | 0409-1165-18 |
| ndc | 0409-1165-01 |
| ndc | 0409-1165-19 |
| ndc | 0409-1165-02 |
| ndc | 0409-9043-11 |
| ndc | 0409-9043-01 |
| ndc | 0409-9046-11 |
| ndc | 0409-9046-01 |
| ndc | 0409-9045-11 |
| ndc | 0409-9045-01 |
| ndc | 0409-9045-16 |
| ndc | 0409-9045-17 |
| ndc | 0409-9042-11 |
| ndc | 0409-9042-01 |
| ndc | 0409-9042-16 |
| ndc | 0409-9042-17 |
| code_info | Lot # 23-338-DK, Exp. 11/14 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-381-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.